Newest
-
AI Market: Opening a new era of AI quantitative finance
-
《Why are global institutional platforms misunderstood? Breaking misunderstandings and panic: Aureston Capital Ltd officially clarifies the SC watch list incident》
-
Meme Ecosystem Co-construction Conference Successfully Concludes in Malaysia, Minidoge Ignites the Audience with Innovative Vision
-
Family business '\u00a310,000 out of pocket' after Meta blocks their accounts for 12 weeks
Business Information
-
Neuromodulation Wristband ObeEnd Reduces Heart Rate and Perceived Exercise Exertion
VANCOUVER,BC,Jan. 13,2025-- WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd,the neuromodulation device designed by WAT for weight and he
01-14
Details -
Yiwu Brands Unite for Overseas Expansion with Grand Opening of Yiwu Selection Store
YIWU,China,Jan. 13,2025-- Yiwu,the world\'s preeminent hub for small commodities,hosts an extensive trading network connecting the globe with 47 industries and 12 million products. As competition in t
01-14
Details -
COSRX Celebrates Global Success at SeoulCon's K-Beauty Boost Event
NEW YORK,Jan. 13,2025--COSRX,a trailblazer in the K-Beauty industry,wrapped up 2024 on a high note by participating in the K-Beauty Boost at SeoulCon,a prominent year-end creator conference hosted by
01-14
Details -
LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025
Exhibition booth attracts 65,000 cumulative visitors,showcasing innovative mobility components Innovative technologies presented through a \'User-Centric storytelling\' approach elicit strong acclaim
01-14
Details -
Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing
ONTARIO,Calif.,Jan. 13,2025-- Nature\'s Miracle Holding,Inc. (Nasdaq: NMHI) ("Nature\'s Miracle"),a growing agriculture technology company providing equipment and services to growers,announc
01-14
Details -
Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity
Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau
01-13
Details -
EngineAI Debuts at CES 2025 with Revolutionary Robotics Lineup
LAS VEGAS,Jan. 10,2025-- On Jan 7-10,Shenzhen EngineAI Robotics,an innovator in humanoid robots,debuted at the prestigious CES 2025,showcasing its humanoid robots: the SE01,SA01,and PM01. These robots
01-11
Details -
China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly
HONG KONG,Jan. 10,2025-- The \'Digital Travel Dilemma\' of the Elderly The internet is evolving at an unprecedented pace,significantly enhancing convenience for young people,while the elderly are in
01-11
Details -
XPPen Unveils Artist Pro 22 (Gen 2) with 2.5 K High-Performance 22-inch Drawing Display
LOS ANGELES,Jan. 10,2025-- Today,XPPen has officially launched a remarkable addition to its professional digital drawing display lineup: the Artist Pro 22 (Gen 2),a 22-inch unparalleled drawing displa
01-11
Details -
EngineAI Debuts at CES 2025 with Revolutionary Robotics Lineup
LAS VEGAS,Jan. 10,2025-- On Jan 7-10,Shenzhen EngineAI Robotics,an innovator in humanoid robots,debuted at the prestigious CES 2025,showcasing its humanoid robots: the SE01,SA01,and PM01. These robots
01-11
Details